Bibliografía del artículo
1. Aagaard-Tillery KM, Belfort MA. Eclampsia: morbidity, mortality, and management. Clin Obstet Gynecol 48:12-23, 2005.
2. Atallah AN, Hofmeyr GJ, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev 1:CD001059, 2001.
3. Barton JR, Sibai BM. Diagnosis and management of hemolysis, elevated liver enzymes, and low platelets syndrome. Clin Perinatol 31:807-33, 2004.
4. Baxter JK, Weinstein L. HELLP syndrome: the state of the art. Obstet Gynecol Surv 59:838-45, 2004.
5. Cetin A. Eclampsia. In Mohler III ER, Townsend RR. Advanced therapy in hypertension and vascular disease. Ontario: B.C. Decker Inc. pp. 407-15, 2006.
6. Cetin A. Hemolysis, elevated liver enzymes, and low platelets (HELLP). In Mohler III ER, Townsend RR. Advanced therapy in hypertension and vascular disease. Ontario: B.C. Decker Inc. pp. 416-20, 2006.
7. Chappell LC, Seed PT, Briley AL, Kelly FJ, Lee R, Hunt BJ, Parmar K, Bewley SJ, Shennan AH, Steer PJ, Poston L. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet 354:810-16, 1999.
8. Cunningham FG, Femandez CO, Hemandez C. Blindness associated with pmeclampsia and eclampsia. Am J Obstet Gynecol 172:1291-98, 1995.
9. Douglas KA, Redman CW. Eclampsia in the United Kingdom. BMJ 309:1395-400, 1994.
10. Duley L, Gulmezoglu AM, Henderson-Smart DJ. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev 2:CD000025, 2003.
11. Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynaecol 99:547-53, 1992.
12. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. JAMA 273:413-8, 1995.
13. Egerman RS, Sibai BM. HELLP syndrome. Clin Obstet Gynecol 42:381-9, 1999.
14. Gul A, Cebeci A, Aslan H, Polat I, Ozdemir A, Ceylan Y. Perinatal outcomes in severe preeclampsia-eclampsia with and without HELLP syndrome. Gynecol Obstet Invest 59:113-8, 2005.
15. Henry CS, Biedermann SA, Campbell MF, Guntupalli JS. Spectrum of hypertensive emergencies in pregnancy. Crit Care Clin 20:697-712, 2004.
16. Hjartardottir S, Leifsson BG, Geirsson RT, Steinthorsdottir V. Recurrence of hypertensive disorder in second pregnancy. Am J Obstet Gynecol 194:916-20, 2006.
17. Hunt CM, Sharara AI. Liver disease in pregnancy. Am Fam Physician 59:829-36, 1999.
18. Isler CM, Rinehart BK, Terrone DA, Martin RW, Magann EF, Martin JN Jr. Maternal mortality associated with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 181:924-28, 1999.
19. Leitch CR, Cameron AD, Walker JJ. The changing pattern of eclampsia over a 60-year period. Br J Obstet Gynaecol 104:917-22, 1997.
20. Longo SA, Dola CP, Pridjian G. Preeclampsia and eclampsia revisited. South Med J 96:891-9, 2003.
21. Lu JF, Nightingale CH. Magnesium sulfate in eclampsia and pre-eclampsia: pharmacokinetic principles. Clin Pharmacokinet 38:305-14, 2000.
22. Magann EF, Martin JN Jr. Critical care of HELLP syndrome with corticosteroids. Am J Perinatol 17:417-22, 2000.
23. Magnesium sulfate. Dimens Crit Care Nurs 18:24, 1999.
24. Martin JN Jr, Rinehart B, May WL, Magann EF, Terrone DA, Blake PG. The spectrum of severe preeclampsia: comparative analysis by HELLP syndrome classification. Am J Obstet Gynecol 180:1373-84, 1999.
25. Matchaba P, Moodley J. Corticosteroids for HELLP syndrome in pregnancy. Cochrane Database Syst Rev 1:CD002076, 2004.
26. Mattar F, Sibai BM. Eclampsia. VIII. Risk factors for maternal morbidity. Am J Obstet Gynecol 182:307-12, 2000.
27. McCrae KR, Samuels P, Schreiber AD. Pregnancy-associated thrombocytopenia: pathogenesis and management. Blood 80:2697-714, 1992.
28. Moller B, Lindmark G. Eclampsia in Sweden, 1976-80. Acta Obstet Gynecol Scand 65:307-14, 1986.
29. Mutter WP, Karumanchi SA. Molecular mechanisms of preeclampsia. Microvasc Res Epub ahead of print, 2007.
30. Naylor DF Jr, Olson MM. Critical care obstetrics and gynecology. Crit Care Clin 19:127-49, 2003.
31. Polley LS. Anesthetic management of hypertension in pregnancy. Clin Obstet Gynecol 46:688-99, 2003.
32. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 183:S1-S22, 2000.
33. Saftlas AF, Olson DR, Franks AC, Atrash HK, Polaras R. Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986. Am J Obstet Gynecol 163:460-65, 1990.
34. Shah DM, Shenai JP, Vaughn WK. Neonatal outcome of premature infants of mothers with preeclampsia. J Perinatol 15:264-7, 1995.
35. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 102:181-92, 2003.
36. Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 103(5 Pt 1):981-91, 2004.
37. Sibai BM, el-Nazer A, Gonzalez-Ruiz A. Severe preeclampsia-eclampsia in young primigravid women: Subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol 155:1011-16, 1986.
38. Sibai BM. Magnesium sulfate prophylaxis in preeclampsia: Lessons learned from recent trials. Am J Obstet Gynecol 190:1520-6, 2004.
39. Sibai BM, Mercer B, Sarinoglu C. Severe preeclampsia in the second trimester: Recurrence risk and long-term prognosis. Am J Obstet Gynecol 165:1408-12, 1991.
40. Smyth B. Pre-eclampsia. In Mohler III ER, Townsend RR. Advanced therapy in hypertension and vascular disease. Ontario: B. C. Decker Inc. pp. 394-406, 2006.
41. Solomon CG, Seely EW. Hypertension in pregnancy. Endocrinol Metab Clin North Am 35:157-71, 2006.
42. Subtil D, Goeusse P, Puech F, Lequien P, Biausque S, Breart G, Uzan S, Marquis P, Parmentier D, Churlet A; Essai Regional Aspirine Mere-Enfant (ERASME) Collaborative Group. Aspirin (100 mg) used for prevention of pre-eclampsia in nulliparous women: the Essai Regional Aspirine Mere-Enfant study (Part 1). BJOG 110:475-84, 2003.
43. The Collaborative Eclampsia Trial Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 345:1455-63, 1995.
44. Van Runnard Heimel PJ, Franx A, Schobben AF, Huisjes AJ, Derks JB, Bruinse HW. Corticosteroids, pregnancy, and HELLP syndrome: A Review. Obstet Gynecol Surv 60:57-70, 2005.
45. Witlin AG. Prevention and treatment of eclamptic convulsions. Clin Obstet Gynecol 42:507-18, 1999.
46. Ziaei S, Hantoshzadeh S, Rezasoltani P, Lamyian M. The effect of garlic tablet on plasma lipids and platelet aggregation in nulliparous pregnants at high risk of preeclampsia. Eur J Obstet Gynecol Reprod Biol 99:201-6, 2001.